New malaria drug candidate shows promise in Phase I trial

The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was generally well tolerated in infected volunteers, showing it is a promising candidate for uncomplicated ...

FDA approves another over-the-counter naloxone nasal spray

The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted ...

page 19 from 40